Injury guide
Have Parkinson’s at a young age and possible paraquat exposure? Age alone does not prove cause.
Updated Oct 4, 202615 sources
See If You Qualify
Free · No obligation · About 2 minutes
Updated Oct 4, 202615 sources
This may apply to you if
These are cited sources. Their inclusion does not imply that they endorse People’s Justice or reviewed this page.
Srishti Shrestha · Epidemiology Branch, National Institute of Environmental Health Sciences · First author, Agricultural Health Study Parkinson cohort
Finding: The prospective cohort did not find a statistically significant overall association for reported paraquat use. Exposure and disease measurement limits prevent treating that as proof of no possible effect.
Shrestha: pesticides and incident Parkinson disease, original cohort (opens in a new tab) · Sep 10, 2020 · Checked Oct 3, 2026
Kimberly C. Paul · Department of Neurology, University of California, Los Angeles · First author of the cited agricultural exposure case-control study
Finding: Modeled historical paraquat applications were associated with Parkinson disease under several exposure measures and periods; proximity is not personal dose or a legal acceptance boundary.
Paul: agricultural paraquat applications and Parkinson disease, original case-control study (opens in a new tab) · Feb 2, 2024 · Checked Oct 3, 2026
National Institute of Environmental Health Sciences, first-author affiliation · Environmental Research · 2020
Read the source: Pesticide use and incident Parkinson disease in the Agricultural Health Study (opens in a new tab) · Checked Oct 3, 2026
University of California, Los Angeles, first-author affiliation · International Journal of Epidemiology · 2024
Read the source: Agricultural paraquat dichloride applications and Parkinson disease (opens in a new tab) · Checked Oct 3, 2026
Not covered by this case
The process
You answer a few questions
About two minutes. Nothing is sent until you agree on the last step and press submit.
A lawyer looks at it
A lawyer at the firm reads your answers and checks them against the current case criteria.
The firm decides and gets in touch
If the firm takes your case, you get the terms in writing to read before you sign. You can always say no.
Have Parkinson’s at a young age and possible paraquat exposure? Age alone does not prove cause. Keep the care and exposure dates. Ask a doctor and lawyer for separate checks.
The disease can begin before the usual older-adult years. Age does not identify the cause by itself. Ask the doctor to explain the actual findings.
The clinical reference notes that Parkinson’s can occur in younger adults and sometimes has a genetic role. That does not prove or rule out an environmental contribution for one person. Keep the diagnosis distinct from a legal claim about exposure.
Tell the doctor about shaking, stiff muscles or slow movement. Note when they began and how they affect you. Ask for a care check before a claim label.
NIH says symptoms can start gradually and later affect more daily tasks. The course differs from one person to another. A young age or a job near farms should not replace an examination or establish that every movement problem is Parkinson’s.
Ask which clinical findings support the diagnosis. Some tests help rule out other problems. Do not assume one scan or treatment is required for a claim.
The clinical reference describes a history and exam, with additional tests in selected situations. Care choices and their effects vary. Discuss medicines and other options with the clinician; this guide does not choose a drug or forecast future disability.
No. The study’s age groups are not a rule for your diagnosis or case. Its exposure estimates still have limits.
The California study compared age at its index date of 60 or under versus over 60; it did not establish an under 50 legal threshold. The overall cohort result was not statistically significant. These observational findings need their design and exposure-measure limits, not a promise that youth proves a stronger case.
Ask about the exposure, care reports and law. Age alone does not mean a firm takes your claim. Have a lawyer check your own filing time.
EPA’s review and a research subgroup do not calculate a person’s filing period. Keep work and residence dates with the clinical records. Explain what is known and uncertain without changing an account to fit an advertised age or distance screen.
Keep the diagnosis, care dates and exposure documents you have. Ask about missing health files. Read the legal fee and case-cost terms.
Covered-record access has exceptions and does not give every helper automatic authority. Keep original reports rather than substituting a product headline for a clinical finding. Confirm the next action and representation terms; gathering records is not an award or a guarantee that a firm takes the case.
Syngenta’s corporate predecessor ICI identified paraquat neurotoxicity in 1958 and confirmed brain penetration in 1966
Paraquat exposure was associated with an overall odds ratio of 1.64 for Parkinson’s disease, confirming a statistically significant increased risk
People who reported using paraquat had about 2.5 times the odds of Parkinson’s disease (odds ratio 2.5; 95% CI 1.4–4.7)
The review is free and private. Asking for it doesn’t commit you to anything.
Register your interestNo. EPA's paraquat page discusses safety restrictions, poisoning risk, and Parkinson's research; it does not set claim values. What any claim is worth depends on its facts, proof, and governing law. Ask for any valuation method in writing.
Source: EPA: Paraquat Dichloride review and safety · as of Oct 7, 2026
Yes. Research suggests that early-onset Parkinson’s disease (diagnosed before age 50) is more strongly associated with environmental exposures like paraquat than late-onset cases. The reasoning is that younger individuals are less likely to develop Parkinson’s from age-related degeneration alone, making environmental factors a more prominent contributor. Studies have found that occupational pesticide exposure is a stronger risk factor for early-onset than late-onset Parkinson’s. In the litigation, early-onset diagnosis strengthens the causation argument because it is more difficult for defendants to attribute the disease solely to aging when the patient is in their 40s or 50s.
Yes, in many cases. While some Parkinson’s cases have a strong genetic component (particularly those associated with LRRK2, PARK7, PINK1, or SNCA gene mutations), genetics and environmental exposure are not mutually exclusive. Research demonstrates that genetic predisposition and paraquat exposure interact synergistically — individuals with certain genetic variants who are also exposed to paraquat face a dramatically higher risk than either factor alone. The legal standard does not require paraquat to be the sole cause of your Parkinson’s disease; it requires that paraquat exposure was a substantial contributing factor. If you carry a genetic variant associated with Parkinson’s and were also exposed to paraquat, your claim may still be viable. An attorney can evaluate the specific interplay of genetics and exposure in your case.
Checked against 13 primary sources by People's Justice editors · Updated
How we make moneyPeople's Justice research team · Updated Oct 4, 2026